Weight loss injections are prescription medications. They are not supplements you buy over the counter, and they are not a quick fix. They work by targeting the hormones in your body that control hunger, blood sugar, and digestion.

Most of these medications belong to a class called GLP-1 receptor agonists. GLP-1 is a natural hormone your body releases after you eat. It tells your brain you are full, slows down digestion, and helps regulate blood sugar. These injections mimic that hormone but at a much stronger level so your appetite drops significantly, and your body starts using stored fat for energy.

The result? You eat less without feeling miserable, and over months, the weight comes off steadily.

Wegovy was the first major weight loss injection to get FDA approval specifically for obesity treatment, back in 2021. It contains semaglutide, a GLP-1 receptor agonist, and is injected once a week under the skin.

How much weight can you lose with Wegovy?

In clinical trials, people taking Wegovy lost an average of around 15% of their body weight over 68 weeks. In real-world studies published in 2025, patients using semaglutide 2.4mg lost an average of 14.1% of their body weight after one year of treatment.

That means if you weigh 200 pounds, you could expect to lose roughly 28 to 30 pounds over the course of a year while also making dietary changes.

Who is Wegovy for?

Wegovy is prescribed for adults who:

• Have a BMI of 30 or higher (clinically obese), or
• Have a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes

Dosing: Wegovy starts at a low dose of 0.25mg per week and is gradually increased over several months to the full dose of 2.4mg per week. This gradual increase helps your body adjust and reduces side effects.

Common side effects: Nausea is the most reported side effect, especially in the first few weeks. Most people find it becomes manageable as the body adjusts. Other common side effects include vomiting, diarrhea, constipation, and stomach discomfort.

Zepbound is the newer injection on the market, approved by the FDA in November 2023. It contains tirzepatide and works differently from Wegovy in one important way: it targets two hormones instead of one.

Zepbound activates both GLP-1 receptors and GIP receptors. GIP is another natural gut hormone that plays a role in fat storage and metabolism. By targeting both hormones at the same time, Zepbound delivers stronger weight loss results than a single-hormone approach.

How much weight can you lose with Zepbound?

The clinical trial results here are impressive. In the SURMOUNT-1 trial, people taking the highest dose of Zepbound (15mg) lost an average of 20.9% of their body weight over 72 weeks. At the 10mg dose, average weight loss was 19.5%, and at 5mg it was 15%.

In the head-to-head SURMOUNT-5 trial, published in the New England Journal of Medicine in May 2025, Zepbound was directly compared to Wegovy for the first time. Participants on Zepbound lost an average of 20.2% of body weight, compared to 13.7% for those on Wegovy — over the same 72-week period. That is roughly 47% more weight lost with Zepbound than with Wegovy.

To put it in real terms: if you weigh 250 pounds, Zepbound could help you lose around 50 pounds over 72 weeks, compared to around 34 pounds with Wegovy.

Who is Zepbound for?

The eligibility criteria are similar to Wegovy:

• Adults with a BMI of 30 or higher, or
• Adults with a BMI of 27 or higher with at least one weight-related condition

Dosing: Zepbound also starts low (2.5mg per week) and is stepped up gradually to a maximum of 15mg per week. It is self-injected once a week.

Common side effects: Side effects are very similar to Wegovy. In SURMOUNT-5, about 44% of participants in both drug groups experienced nausea, and around 25% reported abdominal pain. These are generally mild to moderate and tend to improve with time.

You may have noticed that Zepbound and Tirzepatide sound related — and they are. Tirzepatide is the active ingredient in Zepbound, just as semaglutide is the active ingredient in Wegovy.

Tirzepatide is also sold under another brand name — Mounjaro — which was originally approved for type 2 diabetes management. When doctors and patients refer to tirzepatide for weight loss, they are talking about the same molecule that powers Zepbound.

So when someone asks "should I take Zepbound or Tirzepatide?" — the answer is that they are the same medication. Zepbound is simply the brand name for tirzepatide when used specifically for weight management.

Why does this matter for you?

In some markets, tirzepatide may be available under the Mounjaro brand name rather than Zepbound. The active ingredient, the mechanism, and the results are identical. Always confirm with your doctor which version is available and appropriate for your situation.

This is the question most people want answered. Here is a straightforward comparison based on the latest clinical data.

The data from SURMOUNT-5 clearly shows that Zepbound produces greater weight loss than Wegovy. However, both medications are highly effective compared to placebo, and the right choice depends on your individual health history, how your body responds, and what your doctor recommends.

Some people may also respond better to one medication than the other human physiology varies, and weight loss medication is not one size fits-all.

Do You Need a Prescription for These Injections?

Yes without exception.

Wegovy, Zepbound, and Tirzepatide are all prescription-only medications. No legitimate clinic or pharmacy will dispense them without a valid prescription from a licensed doctor. This is not just a legal requirement it is a safety measure.

These medications can interact with other drugs, and they are not appropriate for everyone. People with a personal or family history of certain thyroid cancers or pancreatitis should not use them. Anyone considering these injections should have a thorough consultation with a doctor first.

Be very cautious of any website or seller offering these medications without asking for a prescription. Compounded or unregulated versions of semaglutide and tirzepatide have caused harm in some cases. Always go through a licensed medical provider.

Starting one of these medications is not like flipping a switch. Here is a realistic picture of what the first few months look like:

Weeks 1 to 4: You are on the lowest dose. You may notice a slight reduction in appetite. Side effects like nausea can occur, especially after your injection day.

Months 2 to 3: The dose increases. Appetite suppression becomes more noticeable. Many people start seeing weight changes during this phase.

Months 3 to 6: Consistent weight loss becomes visible. Most people report that food cravings reduce significantly, and they feel satisfied with smaller portions.

Months 6 to 12 and beyond: Weight loss continues, though the rate may slow. This is where lifestyle habits better food choices and regular movement become important for sustaining results.

These medications work best when combined with a calorie-appropriate diet and regular physical activity. They are a medical tool to make those lifestyle changes more manageable not a replacement for them.

Can I take these injections if I have diabetes?

Tirzepatide (as Mounjaro) and semaglutide (as Ozempic) were both originally developed for type 2 diabetes. If you have diabetes and are also dealing with obesity, your doctor may prescribe the diabetes version of the medication. Wegovy and Zepbound are specifically for weight management. Always discuss your full medical history with your doctor.

How long do I need to stay on the injection?

Obesity is a chronic condition, and these medications may need to be taken long-term to maintain results. Studies show that people who stop the medication often regain weight. Your doctor will guide you on the right duration based on your goals and health profile.

Are these injections safe long-term?

Both semaglutide and tirzepatide have been studied extensively in large clinical trials. The long-term safety profiles are considered acceptable by regulatory agencies. That said, ongoing monitoring by a healthcare provider is essential.

What happens if I miss a dose? 

If you miss a dose and your next scheduled dose is more than 2 days away, take it as soon as you remember. If your next dose is less than 2 days away, skip the missed dose and continue on your regular schedule. Never double up on doses.

Weight loss injections are not a shortcut they are a serious medical intervention that works when used correctly, under the supervision of a licensed doctor, alongside healthy lifestyle habits.

Wegovy has helped millions of people lose meaningful amounts of weight since 2021. Zepbound and Tirzepatide have now shown even stronger results in clinical trials, with head-to-head data confirming greater weight loss compared to Wegovy.

If you have struggled to lose weight through diet and exercise alone, speak with a doctor to find out whether one of these medications is right for you. A proper consultation, an honest conversation about your health history, and a valid prescription are the first steps.